Samsung Biologics Co Ltd (207940.KS) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea · ISIN KR7207940008
Samsung Biologics Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 3.50 tn KRW | 4.56 tn KRW |
| Gross profit | 1.71 tn KRW | 2.52 tn KRW |
| Operating income | 1.32 tn KRW | 2.07 tn KRW |
| EBIT | 1.42 tn KRW | 2.15 tn KRW |
| Net income | 1.08 tn KRW | 1.78 tn KRW |
| Diluted EPS – continuing operations | 15,220.67 KRW | 38,546.46 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Samsung Biologics Co Ltd
Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
More stocks
- Givaudan SA (GIVN.SW)
- Waters Corporation (WAT)
- East Money Information Co Ltd (300059.SZ)
- Aena SME SA (AENA.MC)
- Dr Ing hc F Porsche (P911.DE)
- HEICO CORP (HEI)
- Shengyi Technology Co Ltd (600183.SS)
- Orange SA (ORA.PA)
- Japan Post Holdings Co Ltd (6178.T)
- Sumitomo Electric Industries Ltd (5802.T)
- Wuliangye Yibin Co Ltd (000858.SZ)
- Idexx Laboratories (IDXX)
Not investment advice. All data without warranty, price as of 15.10.2026. Details in the risk notice.